Eimear E Kenny, PhD
- DIRECTOR, INSTITUTE FOR GENOMIC HEALTH
- ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
- ASSOCIATE PROFESSOR | Medicine, General Internal Medicine
Research Topics:Genetics, Genomics
Dr. Eimear Kenny, PhD, is Founding Director of the Center for Genomic Health, and Associate Professor of Medicine and Genetics and Genomic Sciences as well as the Icahn Institute for Data Science and Genomic Technology at Mount Sinai. She is a statistical and population geneticist by training. She leads a multi-disciplinary team focused on solving problems at the interface of genetics, ancestry and medicine. She is Principal Investigator in multiple NIH-funded consortia focused on genomic medicine and health, including NHGRI Clinical Sequencing Evidence-based Research, NHGRI Genome Sequencing Project, and NHLBI Trans-omics in Precision Medicine. She is a scientific advisor to many genomic medicine initiatives in government, non-profit and industry arenas. She has published over 70 papers in leading journals like Science, Nature, Nature Genetics, NEJM, and her work has been featured by the New York Times, Australian Broadcasting Company and at the Smithsonian Human Genome Exhibit in Washington DC.
Dr. Kenny has a BA in Biochemistry from Trinity College Dublin, a PhD in computational genomics from Rockefeller University, and did her postdoctoral training in population genomics at Stanford University.
Multi-Disciplinary Training AreaGenetics and Data Science [GDS]
BSc, Trinity College Dublin
MSc, University of Leeds
PhD, Rockefeller University
Post-doc, Stanford University
Dr. Kenny is Founding Director of the Center for Genomic Health (CGH). She leads a multidisciplinary team of geneticists, computer scientists, clinicians, and other medical professionals, working on problems at the interface of computational genomics and medicine. Her goal is to bring state-of-the-art genomic technology and data science to improve clinical care, particularly in diverse and medically underserved populations. Current activities in CGH include genomic discovery in biobanks and disease cohorts using databases of hundreds of thousands of human genomes; a large clinical trial to examine how complex genomic information is communicated in health systems; and a program to offer genomic screening in clinical care to enable early detection and prevention of diseases, such as breast cancer, diabetes and heart disease. She is scientific advisor to multiple genomic medicine initiatives in non-profit, government and industry arenas.